Skip to main content
Signal8

Kuan Arthur

SEC insider (Form 3/4/5 filer). CIK 0002007101. Chief Executive Officer at CG Oncology, Inc. (CGON). 7 reported Form 4/5 transactions since Sep 2024; latest on Apr 15, 2026. Located in DALLAS, TX.

Companies Kuan Arthur has filed insider reports for

  • CG Oncology, Inc. (CGON): Director, Officer, Chief Executive Officer
Kuan Arthur profile photo

Kuan Arthur

CIK: 0002007101

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CG Oncology, Inc. logo
CGON

CG Oncology, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Apr 15, 2026
    Award

    Employee Stock Option (Right to Buy)

    Direct
    271.6K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Mar 12, 2026
    Exercise
    Direct
    64.6K shares at avg. $1.72$111K
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Mar 12, 2026
    Tax Payment
    Direct
    1.8K shares at avg. $60.15$111K
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Mar 4, 2026
    Exercise
    Direct
    102.9K shares at avg. $1.72$177K
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Mar 4, 2026
    Tax Payment
    Direct
    2.9K shares at avg. $61.61$177K
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Apr 15, 2025
    Award

    Employee Stock Option (Right to Buy)

    Direct
    527.7K shares-
  • CG Oncology, Inc. logo
    CGON

    CG Oncology, Inc.

    Oct 4, 2024
    Award

    Stock Option (Right to Buy)

    Direct
    397.8K shares-

1-7 of 7